Pfizer: Global regulatory divergence restricted continuous manufacturing ambition

A Big Sight for saw eyes: Pfizer talks continuous manufacturing in Tokyo

Pfizer says a lack of harmony among regulators made its continuous granulation platform untenable for bulk manufacturing but is positive about using such tech for smaller volumes.

iStock/Tashatuvango

Opiant has new Narcan nasal spray patent listed in US FDA orange book

iStock/macgyverhh

PE firms' plan to take AMRI private on track

iStock/bodym

Microneedle patch stable, painless and simple say researchers

iStock/BartekSzewczyk

Pharma executives make a move: recent appointments

iStock/Sergey Khakimullin

Pfizer starts work on Missouri biotherapeutics R&D hub

iStock/Kagenmi

Mexico legalizes medical marijuana: a boon for pharma?

See More Headlines

Regulatory & Safety

iStock/ymgerman

Open for comment: US FDA confirms backing for continuous manufacturing and calls for industry input

iStock/Vepar5

Brazil tells Bayer to recall 13 lots of Gynera contraceptive

iStock/wawritto

Fagron and Advanced Pharma pull drugs made at Pfizer's Rocky Mount site

See More in Regulatory & Safety

Ingredients

iStock/Zerbor

BASF to spend €200m to up ibuprofen capacity in Europe and US

iStock/Cakeio

Grace to start making fluorinated drug intermediates with tech from Valliscor

Source Google maps

Tetraphase hires Patheon to make its synthetic antibiotic eravacycline

See More in Ingredients

Drug Delivery

iStock/AlexLMX

Lonza’s $5.5bn Capsugel takeover cleared by regulators

iStock/kmatija

Zynerba starts Ph I study of cannabinoid pain patch

iStock/stockce

Adamis has not set US price for newly approved rival to Mylan's $600 EpiPen

See More in Drug Delivery

Processing

iStock/ismagilov

EMA clears Janssen to make HIV drug using continuous manufacturing approach

Image: iStock/Totojang

Corning life science focus: '21st century glass for 21st century drugs'

Image: iStock/Fredex8

Takeda inaugurates €100m German oral solid dose plant

See More in Processing

Popular News

iStock/egal

Europe tells API firms UK will be a “third country” like India and China after Brexit

iStock/Ildo Frazao

Pfizer recalls injectables made at Rocky Mount over potential contamination risk

iStock/ismagilov

EMA, FDA and PMDA aim to give antibiotic firms option of global trial programme

Galleries

Videos

Audio

Latest Products

See more products